P2RX4 and gout: However, P2X4 selective antagonists have not been tested in the context of SCI yet.42 Probenecid has already been used as a commercial drug in the treatment of gout, making it the closest to a practical application of the drug as an inhibitor of the inflammasome in the treatment of SCI.